Lenacapavir-associated drug resistance: implications for scaling up long-acting HIV pre-exposure prophylaxis
{{output}}
Although drug resistance could emerge if lenacapavir is initiated during undiagnosed acute infection or if infection occurs during the drug's pharmacokinetic tail, these cases will not compromise the effectiveness of WHO-recommended therapies, as there is no ... ...
